BTK inhibitor 18 is a potent, selective,orally active and covalent Btk inhibitor with a IC 50 of 142 nM. BTK inhibitor 18 has anti-inflammatory activities. IC50& Target:IC50: 142 nM (Btk) In Vitro:BTK inhibitor 18 (Compound 27) irreversibly inhibits BTK by targeting a noncatalytic cysteine residue (Cys481) for covalent bond formation. BTK inhibitor 18 (Compound 27) inhibits anti-IgM-induced activation of B cells in human whole blood with an IC In Vivo:BTK inhibitor 18 (Compound 27; 1-30mg/kg; oral administration; once a day; for 7 days) treatment shows dose-dependent efficacy at reducing joint inflammation in a rat collagen-induced arthritis model. The IV and PO pharmacokinetics of BTK inhibitor Biological Activity:BTK inhibitor 18 is a potent, selective,orally active and covalent Btk inhibitor with a IC 50 of 142 nM. BTK inhibitor 18 has anti-inflammatory activities.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
BTK inhibitor 18
CAS number：unknown molecular formula：C29H25N5O4S2
overview
compound introduction
Specs
| Chinese alias | BTK抑制剂18 | ||
| English alias | - | ||
| CAS number | unknown | molecular formula | C29H25N5O4S2 |
| molecular weight | 571.67 g/mol | Exact mass | - |
| PSA | - | logp | - |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
